Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Endothelial Damage in Chronic Kidney Disease
NCT04983160Phase 2Completed
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Feb 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol in chronic kidney disease (CKD), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Started Feb 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04983160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04983160.